Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
about
Prodrug Strategies for PaclitaxelAntibody drug conjugates: design and selection of linker, payload and conjugation chemistryDevelopment and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic CancerIntracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor.Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapySynthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.Antibody-cytotoxic agent conjugates for cancer therapy.Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant--taxoid conjugates as novel cytotoxic agents.Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy.Analytical methods for physicochemical characterization of antibody drug conjugatesThe impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis.Tumour vasculature targeting agents in hybrid/conjugate drugs.Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.Preparation of anti-HER2 monoclonal antibody-paclitaxel immunoconjugate and its biological evaluation.
P2860
Q26745997-D845FA08-98E5-4BBB-8C0D-0412367A96D3Q28544658-FCAA5FF4-C430-448A-B925-A7CAB7C798F6Q28552050-DC9A8060-9080-477D-8FFC-3174F49B6215Q30434397-122A7826-0139-47A3-8D35-2B8F15CDEA53Q33737986-A2165F1C-6098-4131-91BC-1CD47B62044DQ35368323-146158EB-02A8-4632-B6C2-71C52EA9BB59Q35911710-CF6CF753-2F31-4DCF-8A03-946E9A29051CQ36316831-E6F6FC4B-EAA2-4769-BC09-1D53684AF25AQ36579086-F97E312C-439D-4153-85FF-130C1DF81BEFQ36985913-CC50248F-5F9A-4B63-BADA-0EF7B453832DQ37138420-36E9ADD3-F8D9-4E12-B4FE-00C8F4B1E141Q37858385-C22659FA-BC75-4C5D-A813-8DA9D789FCEEQ38062785-F9429AB7-E56D-4839-80F3-50B143DBA948Q38094627-B9A5736C-A265-44E5-92F7-E23901F7F995Q38489049-1D69C71E-8C8C-4FCE-BB2B-9CCC5E395725Q39427630-585AC5A0-B4BD-4CC0-814E-89040F562EB3
P2860
Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Synthesis and biological evalu ...... el for targeted drug delivery.
@ast
Synthesis and biological evalu ...... el for targeted drug delivery.
@en
type
label
Synthesis and biological evalu ...... el for targeted drug delivery.
@ast
Synthesis and biological evalu ...... el for targeted drug delivery.
@en
prefLabel
Synthesis and biological evalu ...... el for targeted drug delivery.
@ast
Synthesis and biological evalu ...... el for targeted drug delivery.
@en
P2093
P356
P1476
Synthesis and biological evalu ...... del for targeted drug delivery
@en
P2093
Ahmad Safavy
Dung-Tsa Chen
G Yancey Gillespie
Harlan W Waksal
James A Bonner
Kevin P Raisch
M B Khazaeli
Mark Carpenter
Ramin Arani
P304
P356
10.1021/BC020033Z
P577
2003-03-01T00:00:00Z